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a b s t r a c t
Percutaneous transhepatic biliary drainage (PTBD) is commonly used in the management of cholan-
giocarcioma. Major and minor complications of PTBD such as cholangitis, haemorrhage and catheter
dislocation are well documented. A lesser reported complication are cutaneous metastases following
PTBD for cholangiocarcinoma.
We report a case of a 79 year old man who presented with right upper quadrant pain, jaundice and
weight loss, with dilated intra-hepatic bile ducts on imaging. The cytology results from a sample taken
during endoscopic retrograde cholangiopancreatography were highly suspicious of cholangiocarcioma.
A PTBD was subsequently performed and bilateral metal biliary stents were placed without external
drainage. Five months after the PTBD he was found to have a hard nodule under the PTBD puncture site.
The nodule was excised and the histology conﬁrmed a cholangiocarcinoma metastasis.
A review of the literature identiﬁed twelve cases of cutaneous metastases from cholangiocarcinoma,
following PTBD. In addition, tumour seeding along the catheter tract following PTBD, with metastatic
deposits on the abdominal wall, peritoneoum, chest wall, pleural space, and liver parenchyma have also
been reported.
Health care professionals should be aware of this rare complication and offer appropriatemanagement
© 
options to patients.
. Introduction
Cholangiocarcinomas are rare and account for 3% of all gas-
rointestinal tumours.1 They are malignant neoplasms which arise
rom the biliary ductular epithelium. Cholangiocarcinomas typi-
ally present late,with signsof obstructive jaundice. In such setting,
iver failure and recurrent sepsis fromcholangitis partly account for
he high morbidity and mortality rate associated with this malig-
ancy. Complete surgical resection offers the only chance for cure.
owever, due to the late presentation of the disease, the majority
f patients have unresectable disease at the time of presentation.1
hus, palliative care is themainstay of treatment formany patients.
Percutaneous transhepatic biliary drainage (PTBD) has become
stablished practice in the management of cholangiocarcinomas.
ajor complications of percutaneous transhepatic cholangiogra-
hy (PTC) and PTBD have been reported to occur in fewer than 4%2
nd 7–10%3 of patients respectively. Major complications include
holangitis, haemorrhage, bile leakage and peritonitis.3–5 Minor
omplications, such as catheter dislocation and blockage, local
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infections and granulomas at the catheter entry site have been
reported to occur in 20% of cases.3
Cutaneous metastases from seeding along the catheter tract
following PTBD for cholangiocarcinoma have been reported spo-
radically in the literature4,6–12 and the incidence has been reported
to range between 0.6% and 6%.10
This case report describes a rare case of cutaneousmetastasis at
the PTBD site in a patient with cholangiocarcinoma. In addition, we
conducted a literature review of all documented cases of cutaneous
metastases secondary to cholangiocarcinoma following PTBD.
2. Case report
A 79 year old man presented to his General Practitioner (GP)
with a 2 week history of intermittent right upper quadrant pain,
jaundice, pruritus and weight loss. He was found to have deranged
liver function tests with a bilirubin of 184mol/l, alkaline phos-
phatase of 646U/L, alanine transferase of 223U/L and a CA 19.9 of
Open access under CC BY-NC-ND license.83U/ml. The patient was referred to the fast track jaundice ser-
vice and underwent a liver ultrasound scan which showed dilated
intra-hepatic bile ducts.
A triple phase abdominal computer tomography (CT) scan
demonstrated moderate to severe intrahepatic duct dilatation and
nse.
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n area of abnormal soft tissue (Fig. 1). The appearances were
uggestive of a hilar cholangiocarcinoma, with no evidence of
etastatic disease.
Two days later, the patientwas admittedwithworsening symp-
oms and an endoscopic retrograde cholangiopancreatography
ERCP)was performed. Appearanceswere suggestive of Bismuth IV
ilar cholangiocarcinoma. The left intra-hepatic ducts were grossly
ilated and an 11 cm plastic stent was placed with good effect. The
ight system was completely occluded and it was not possible to
tent it. Cytology brushings taken at ERCP demonstrated epithelial
roups with nuclear enlargement, ﬂat nuclei, loss of polarity and
yperchromatism. The features were highly suspicious of adeno-
arcinoma of biliary epithelium.
Fig. 2. A percutaneous catheter cholangiogram dum and an area of abnormal soft tissue seen anterior to the portal vein and hepatic
The patient was discussed at the regional specialist hep-
atopancreaticobiliary multidisciplinary meeting. As standard, the
surgical management option would have entailed a right por-
tal vein embolisation to allow compensatory hypertrophy of
the relatively small left lobe followed by an extended right
hepatectomy. In view of the patients’ numerous and very
signiﬁcant co-morbidities, including previous cerebrovascular
event, ischaemic heart disease, hypertension, hypercholestero-
laemia and aortic sclerosis palliative management was recom-
mended.
The patient underwent a further ERCP to remove the left sided
plastic stent. A PTBD was subsequently performed (Fig. 2) and
bilateral parallel metal biliary stents were placed successfully as
emonstrating bilateral biliary stents in situ.
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cFig. 3. Palpable nodule at the site of previous PTBD.
primary procedure. No external drain was left in situ and there
ere no immediate complications.
Five months after the PTBD, the patient developed a prominent
ard, non-tender, mobile nodule, measuring approximately 1.5 cm
n diameter adjacent to a smaller mass on his lower right chest
all, immediately under the puncture site from his previous PTBD
Fig. 3).
It caused the patient signiﬁcant discomfort when lying on his
ight side. An ultrasound examination demonstrated two separate
eterogenous subcutaneous lesions on the right chest wall, one
esionmeasured 0.8 cm in diameter and the other was 2 cm×5 cm.
The lesions were removed under local anaesthetic, aiming to
mprove pain control. The microscopic ﬁndings of the histology
howed moderately differentiated adenocarcinoma with luminal
ecroinﬂammatory debris and an associated dense ﬁbrous scle-
otic stroma, suggesting itwasa subcutaneousdeposit ofmetastatic
denocarcinoma. Immunohistochemistry showed the tumour to
e strongly CK7 positive, with patchy co-expression of CK20. TTF-
, CA125 and PSA were all negative. This immunoproﬁle, in the
ontext of the tumour morphology, suggested the primary was a
holangiocarcinoma. The patient died in his own home 3 months
ater.
able 1
atients with cholangiocarcinoma who developed cutaneous metastases following percu
Author Sex Age Histology of
primary
Histology of
metastases
Detection o
metastases
PTBD
Oleaga M 60 No biopsy Adeno 16m
Shorvon M 73 Adeno Adeno 3m
Demas ND ND Adeno ND ND
Tersigni M 66 G1 adeno ND 13m
Tersigni F 79 ND ND 4m
Loew M 67 G2 adeno Adeno 7m
Sakata F 63 G1 adeno ND 14m
Sakata M 70 G2 adeno ND 20m
Sakata M 76 G3 adeno ND 7m
Balzani F 59 Cholangio Adeno 3m
Mizuno ND ND Cholangio Adeno ‘severalm’
Mizuno ND ND Cholangio Adeno ‘severalm’
deno=adenocarcinoma, m=months, RTx= radiotherapy, ICNB= intercostal nerve b
erentiated, CTx= chemotherapy, G2=moderately differentiated, ECT=excision of c
holangio = cholangiocarcinoma, NED=no evidence of disease, AWR=abdominal wall resof Surgery Case Reports 1 (2010) 33–36 35
3. Discussion
During a ﬁve year period in our institution, ﬁfty-nine patients
were diagnosed with cholangiocarcinoma. Twenty-nine (49%)
of these patients underwent PTC or PTBD and one (3.4%) of
twenty-nine patients developed cutaneous metastases following
the procedure.
Twelve cases of cutaneous metastases from cholangiocarci-
noma, following PTBD, were identiﬁed in the literature6,11–17
(Table 1). The average age of the patients was 68.1 (range 59–79).
Six of these patients were male (50%), three patients were female
(25%) and three were not speciﬁed (25%).
The mean time elapsed from PTBD and detection of cutaneous
metastasis was 9 months (range=3–20 months). The mean length
of survival after the detection of cutaneous metastases was 9
months (range=10weeks to 20months). Six patients died as a con-
sequenceof their cholangiocarcinoma (oneof these six patients had
surgical excision of their cutaneousmetastases). The outcome after
the detection of metastases was not documented in three cases.
Three patients were well on follow-up at 8, 12 and 18 months
and they had all underwent surgical resection of the cutaneous
metastasis.
The incidence of cholangiocarcinoma remains low, as such clin-
ical decisions are often based on retrospective studies. PTC and
PTBD has been used in the management of malignant obstructive
jaundice for precise delineation of intrahepatic ductal anatomy,
as palliative treatment in unresectable patients and as a way
in which to reduce serum bilirubin preoperatively in resectable
patients. However, there has been much debate about the ben-
eﬁts of preoperative PTBD. A number of studies have evaluated
the morbidity and mortality associated with pre-operative PTBD.
Several nonrandomized studies favoured the use of pre-operative
PTBD for patients with pre-operative hyperbilirubinaemia.13,14
However, three prospective, randomized studies analysing pre-
operative PTBD demonstrated no advantage for preoperative
drainage.15–17 In fact, McPherson et al. suggested higher mortal-
ity in the PTBD group than the non-PTBD group. Currently, PTC and
PTBD are commonly used as palliative treatment in unresectable
patients.
PTBD is associated with both major and minor complications.
A lesser documented complication is metastatic tumour seeding
along the catheter tract following PTBD, which has been reportedof extension of a cholangiocarcinoma into the drainage catheter
site following PTBD. A retrospective analysis of 67 patients who
underwent PTBD for extrahepatic cholangiocarcinoma found three
taneous transhepatic biliary drainage.
f
after
Time catheter was
in place
Management of
metastases
Outcome after
detection of
metastases
3m RTx & ICNB ND
7 d ND DOD: (5m)
ND ND ND
16 d RTx & CTx DOD: (4m)
4 d ND ND
2m ND DOD: (2.5m)
ND RTx DOD: (20m)
ND ECT DOD: (9m)
ND BSM DOD: (3m)
ND ECT NED: (12m)
ND AWR NED: (18m)
ND AWR NED: (8m)
lock, ND=not documented, d =days, DOD=died of disease, G1=well dif-
atheter tract, G3=poorly differentiated, BSM=best supportive management,
ection & reconstruction.
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19. Shimizu Y, Yasui K, Kato T, et al. Implantation metastasis along the per-6 A. Rosich-Medina et al. / International Jo
atients with catheter tract implantation metastases (Table 1),
hich presented as subcutaneous nodules.10
In addition, there have been reports of metastatic seeding at
he abdominal wall and peritoneum, chest wall and pleural space
nd liver parenchyma following PTBD.5,18,19 Sakamoto conducted
prospective study over a 22 year period, in which 7 of 206 (3.4%)
atients who underwent PTBD developed tumour seeding in the
TBD sinus tract as a late complication. These ﬁndings would sug-
est that the incidence of metastatic tumour seeding along the
iliary catheter tract is not as low as initially suspected. However,
he development of cutaneous metastases following PTBD appears
o be rarer.
The precise mechanism in which these implantation metas-
ases occur remains uncertain. It has been suggested that catheters
hich are left in situ longer and catheters which are manipulated
nd exchanged more frequently increase the risk of metastatic
eeding.20 Tanaka reported that patients who had bile positive
or tumour cells preoperatively were at higher risk of developing
eritoneal metastases and a study byMizuno showed that approx-
mately 30–47% of patients with malignant tumours had tumour
ells within the bile. It therefore seems plausible that the malig-
ant cells in bile may adhere to the biliary catheters during PTBD,
epositing tumour cells on exiting the skin, and hence promoting
he development of cutaneous metastases. The theory of dissem-
nation of malignant cells during guidewire or catheter exchange
ay have accounted for the development of cutaneous metastases
n our patient in whom primary stenting was performed with no
xternal drains in place.
The optimum management for cutaneous metastases from
holangiocarcinoma, following PTBD, remains uncertain. Sev-
ral authors have suggested aggressive surgical resection of
he metastatic deposits to improve morbidity and mortality10,18
articularly in patients with ‘curative disease’. As implantation
etastases are a form of local recurrence rather than systemic
issemination12 achieving negative margins could potentially lead
o long-term survival. Mizuno reported two cases inwhich survival
t 8 and 18monthswas achieved following surgical resection of the
etastatic tumour.
In conclusion, health care professionals should be aware of this
orm of complication in order to offer appropriate support and
anagement options.
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